A comprehensive metabolic evaluation reveals impaired glucose metabolism and dyslipidemia in breast cancer patients early in the disease trajectory

Article ID	Journal	Published Year	Pages	File Type
5871873	Clinical Nutrition	2014	8 Pages	PDF

Abstract

Breast cancer patients present with unhealthy metabolic features early in the disease trajectory. Future investigations need to examine the underlying mechanisms and the potential longitudinal changes following chemotherapy.

Keywords

LDL-C IDF NCEP-ATPIII PAQ DBP HDL-C NEFA SBP VO2peak OGTT AUC c-Peptide Oral glucose tolerance test EDTA Ethylenediaminetetraacetic acid Non-esterified fatty acid insulin interleukin triacylglycerol TAG یا triacylglycerols Nutrition tumor necrosis factor-α Peak oxygen uptake Body composition International Diabetes Federation Cytokines body mass index BMI TNF-α diastolic blood pressure systolic blood pressure high-density lipoprotein cholesterol area under the curve exercise Physical activity questionnaire C-reactive protein CRP Low-density lipoprotein cholesterol

Related Topics

Health Sciences Medicine and Dentistry Critical Care and Intensive Care Medicine

Preview

A comprehensive metabolic evaluation reveals impaired glucose metabolism and dyslipidemia in breast cancer patients early in the disease trajectory

Authors

Kirsten E. Bell, Katie M. Di Sebastiano, Vivienne Vance, Rhona Hanning, Andrew Mitchell, Joe Quadrilatero, Caryl Russell, Joel A. Dubin, Mala Bahl, Nadia Califaretti, Carolyn Campbell, Marina Mourtzakis,